Loading... Please wait...

Akili, Inc. (AKLI) Stock Price, News & Analysis

Currency in USD Disclaimer
$0.43 -$0 (-0.62%)
$0.43
$0.44
$0.19
$1.25

Stock Score/grades

The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company


  • Altman Z Score -6.83
  • Piotroski Score 3.00
  • Grade Outperform

Company brief: Akili, Inc. (AKLI)


Akili, Inc., a digital medicine company, develops digital therapeutics for cognitive impairments. It provides EndeavorRx, a physician-prescribed video game-based treatment designed to directly target cognitive functioning. The company is based in Boston, Massachusetts.

Price Target and Rating


  • $3.25
  • $4.50
  • $2.00
  • N/A
  • Neutral
  • N/A
  • N/A

Profitability


  • -$0.61
  • -0.69
  • -0.69
  • -0.69
  • $-59,493,000

Key Stats

Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.


Latest News of AKLI

The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.


×
New Alert

Select an alert type

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.

New Alert

Setup alert

×

Log In


or

Continue with Google Continue with Apple

Email Verification

An email with a verification code has been sent to your email address.

Welcome to StockNews!

Create Your Account

Email Verification

An email with a verification code has been sent to your email address.